Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Novo Nordisk A/S
Index- P/E27.41 EPS (ttm)1.67 Insider Own- Shs Outstand2.12B Perf Week3.27%
Market Cap96.91B Forward P/E23.06 EPS next Y1.99 Insider Trans- Shs Float1.52B Perf Month-4.21%
Income4.44B PEG2.19 EPS next Q- Inst Own9.00% Short Float0.24% Perf Quarter-0.30%
Sales14.43B P/S6.72 EPS this Y20.50% Inst Trans0.01% Short Ratio3.28 Perf Half Y1.53%
Book/sh2.37 P/B19.31 EPS next Y12.21% ROA39.10% Target Price49.37 Perf Year27.88%
Cash/sh0.52 P/C87.30 EPS next 5Y12.50% ROE68.20% 52W Range32.43 - 49.11 Perf YTD26.19%
Dividend0.61 P/FCF68.02 EPS past 5Y24.60% ROI56.40% 52W High-6.80% Beta0.98
Dividend %1.33% Quick Ratio1.00 Sales past 5Y12.90% Gross Margin83.30% 52W Low41.14% ATR0.91
Employees40226 Current Ratio1.40 Sales Q/Q1.20% Oper. Margin38.10% RSI (14)51.08 Volatility1.70% 1.66%
OptionableYes Debt/Eq0.01 EPS Q/Q7.10% Profit Margin30.60% Rel Volume3.55 Prev Close45.72
ShortableYes LT Debt/Eq0.00 EarningsFeb 02 BMO Payout34.00% Avg Volume1.10M Price45.77
Recom2.00 SMA200.21% SMA50-0.62% SMA2003.20% Volume3,899,126 Change0.11%
28-May-13Upgrade Deutsche Bank Sell → Hold
31-Mar-10Initiated Deutsche Bank Hold
30-Mar-10Downgrade Mehta Partners Outperform → Market Perform
24-Feb-10Upgrade Jefferies & Co Hold → Buy
15-Jan-10Downgrade Jefferies & Co Buy → Hold
11-Sep-09Initiated Jefferies & Co Buy
07-Aug-09Downgrade UBS Buy → Neutral
07-Aug-09Downgrade JP Morgan Overweight → Neutral
12-May-09Initiated Piper Jaffray Buy
24-Apr-09Upgrade Citigroup Hold → Buy
26-Mar-09Upgrade UBS Neutral → Buy
14-Jan-09Downgrade Citigroup Hold → Sell
06-Oct-08Upgrade Deutsche Securities Hold → Buy
29-Aug-08Downgrade Bernstein Mkt Perform → Underperform
21-Aug-08Initiated UBS Neutral
09-Jun-08Upgrade HSBC Securities Underweight → Neutral
26-Feb-08Downgrade Bear Stearns Outperform → Peer Perform
08-Feb-08Upgrade Bernstein Mkt Perform → Outperform
23-Jan-08Upgrade Bear Stearns Peer Perform → Outperform
09-Aug-07Downgrade Lehman Brothers Overweight → Equal-weight
25-Oct-14 01:26AM  [$$] The Perils of One-Country Funds at Barrons.com
23-Oct-14 03:30PM  Eli Lilly/Boehringer's Diabetes Drug Under FDA Review Zacks
16-Oct-14 07:59AM  Media Advisory - Dare to Tell the Truth About Vaginal Atrophy (VA) PR Newswire
07-Oct-14 06:08PM  Actavis, Jazz, Novo Lead Top World Stocks List at Investor's Business Daily
01-Oct-14 02:39PM  3 Companies Helping To Keep Diabetes Rates Lower Benzinga
29-Sep-14 01:03PM  Today's Stocks Driving Success For The Drugs Industry at TheStreet
25-Sep-14 09:08PM  Interim for Novo Resources Corp. Company Spotlight
22-Sep-14 05:20PM  Novo Nordisk Reveals Fresh Data on Xultophy for Diabetes Zacks
18-Sep-14 06:53PM  Five Leading International Stocks Near Buy Points at Investor's Business Daily
05:24PM  Today's Market Thorns, Roses and All Time Highs... Yahoo Finance Blogs
04:52PM  FDA Approves Lilly's Once-Weekly Shot For Diabetes at Forbes
07:59AM  Novo Nordisk Marks 90 Years of Innovating Diabetes Care PR Newswire
17-Sep-14 05:12PM  The Market's Thorns, Roses, and All Time Highs... Yahoo Finance Blogs
05:10PM  Novo Nordisk's Tresiba Effective in Children & Adolescents Zacks
12-Sep-14 04:10PM  Novo Nordisk's Saxenda Gets Positive Opinion for Obesity Zacks
11:49AM  Aveva sinks; Novo Nordisk climbs: Europes big stock movers at MarketWatch
11-Sep-14 06:08PM  [$$] FDA Panel Recommends Approval of Novo Nordisk Obesity Treatment at The Wall Street Journal
07:59AM  MEDIA ALERT: Denmark's Crown Prince Couple Helps Mark 90 Years of Canadian, Danish Partnership in Innovating Diabetes Care CNW Group
10-Sep-14 09:16PM  New Drug to Treat Obesity Gains Approval by F.D.A. at New York Times
10:41AM  Fat Chance? Novo Hopes to Sell its Injectable Diabetes Med as a Diet Drug at The Wall Street Journal
06:15AM  Investment, Un-American Style at Forbes
09-Sep-14 01:04PM  3 Stocks Boosting The Drugs Industry Higher at TheStreet
04-Sep-14 08:06AM  Piramal, Exelixis And Novo Nordisk Research Woes Spell Doom For Drug Discovery Scientists at Forbes
03-Sep-14 05:20PM  Novo Nordisk Drops Anti-Inflammatory R&D Activities Zacks
03:05PM  [$$] Novo Nordisk's Comeback Needs Nods From Regulators at The Wall Street Journal
02-Sep-14 05:42PM  Booming Biotech Market Benefits REIT BioMed Realty at Investor's Business Daily
02:30PM  [$$] Novo's Comeback Hinges on Regulators at The Wall Street Journal
02:00PM  Novo Nordisk's Ryzodeg Now in Mexico for Type II Diabetes Zacks
29-Aug-14 03:30PM  Eli Lilly-Boehringer Drug's Cost Effectiveness Questioned Zacks
28-Aug-14 01:04PM  NVO, BMRN And ILMN, 3 Health Care Stocks Pushing The Sector Lower at TheStreet
27-Aug-14 06:16PM  [$$] Novo Nordisk CEO Has No Plans for Big Acquisitions at The Wall Street Journal
26-Aug-14 09:33AM  [$$] Novo Nordisk CEO Has No Plans for Big Acquisitions at The Wall Street Journal
25-Aug-14 12:09PM  Deal lifts Roche; Draghi boosts banks: Europes stock moves at MarketWatch
19-Aug-14 04:50PM  Novo Nordisk to Pay Fine, Tresiba in Focus Zacks
18-Aug-14 02:58PM  Novo Nordisk Pays for a Weekend Delay at The Wall Street Journal
08-Aug-14 03:10PM  Novo Nordisk's Earnings Rise on Solid Victoza, Levemir Sales Zacks
07-Aug-14 06:50PM  Salix Q2 Misses Estimates; Novo Nordisk, Mylan Slide at Investor's Business Daily
12:04PM  Novo Nordisk, Mylan Miss Views; Mallinckrodt Beats at Investor's Business Daily
02:29AM  [$$] Novo Nordisk's Net Profit Rises at The Wall Street Journal
29-Jul-14 07:15AM  Novo Nordisk Diabetes Drug Xultophy Gets Positive CHMP View Zacks
25-Jul-14 07:30AM  Novo Nordisk receives positive opinion from CHMP at theflyonthewall.com
07:23AM  EMA recommends approval for Novo Nordisk diabetes treatment at theflyonthewall.com
17-Jul-14 08:49AM  [video] Paying for diabetes pandemic at CNBC
16-Jul-14 01:03PM  3 Stocks Advancing The Drugs Industry at TheStreet
11-Jul-14 05:18PM  Is This MannKind's Greatest Risk? at Motley Fool
08-Jul-14 05:40PM  Sanofi's Basal Insulin Candidate Under FDA Review Zacks
10:30AM  Can Dividend Stocks Novo Nordisk and Novartis Continue to Perform? at Motley Fool
10:30AM  Novo Nordisk Gets FDA Nod for NovoSeven RT Zacks
07-Jul-14 06:18PM  Jazz, Novo Among Medicals Showing Healthy Action at Investor's Business Daily
05:03AM  1 Key Question Remains after MannKind's Giant Leap at Motley Fool
05-Jul-14 05:00PM  3 Things to Look for in MannKind's Partnership at Motley Fool
30-Jun-14 05:00PM  Biogen Hemophilia Drugs Launch Into The Unknown at Investor's Business Daily
04:32PM  MannKind's Afrezza Approved but Will Doctors Prescribe It? at Motley Fool
02:02PM  MannKind Stock: Afrezza Approved at Last, But Will Sales Disappoint? at Motley Fool
11:06AM  Up 9%: What You Need to Know About MannKind Today at Motley Fool
10:38AM  Consider Shire Pharmaceuticals Now; 20%+ Upside Left In Takeover Bid By AbbVie at Seeking Alpha
27-Jun-14 02:22AM  MannKind's Clock Is Ticking, But Balance Sheet Sounds An Alarm at Seeking Alpha
26-Jun-14 06:41PM  Novo, Other Medicals Display Healthy Action at Investor's Business Daily
06:05PM  Novo Nordisk's Diabetes Pill Shows Promise at Seeking Alpha
24-Jun-14 11:00AM  Team Novo Nordisk, the world's first all-diabetes professional cycling team, races in BC Superweek CNW Group
01:11AM  Is Sanofi's Dividend Safe? at Motley Fool
23-Jun-14 04:32PM  Sanofi: Toujeo Is Not The Ace In Its Deck at Seeking Alpha
10:30AM  Novo Nordisk Reveals Positive Data on Victoza 3 mg Zacks
12:01AM  Early Results Arrive on Weight-Loss Pills That Expand in the Stomach at New York Times
20-Jun-14 06:24PM  Who Will Win This $45 Billion Market? at Motley Fool
02:32PM  Health Insurers Pressing Down on Drug Prices at New York Times
11:34AM  The Anti-Obesity Space Is Not As Simple As Some Think at Seeking Alpha
18-Jun-14 04:34PM  Is Novo Nordisk's Dividend Safe? at Motley Fool
03:30PM  A Cost of Doing Business? How Regulatory Fines Hurt Shareholder Returns at The Wall Street Journal
08:46AM  Novo Nordisk (NVO) is in Overbought Territory: What's Next? Zacks
17-Jun-14 03:35PM  Ligand Pharma's LGD-6972 Positive in Phase I Study Zacks
12:34AM  [$$] Novo Nordisk Sees 'No Strategic Reason' For Big Mergers at The Wall Street Journal
Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. The Diabetes Care segment covers insulins, GLP-1 analog, obesity, and oral antidiabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth hormone therapy, hormone replacement therapy, and inflammation. The company sells its products primarily in North America, China, Japan, Algeria, Argentina, Australia, Brazil, India, Turkey, and European countries through its subsidiaries, distributors, and independent agents. Novo Nordisk A/S was founded in 1925 and is headquartered in Bagsvaerd, Denmark.